Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New Jersey · 2026-2027 Regular Session · Bill

A 1526: Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 1526 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. Primary sponsor: Clinton Calabrese (Democratic), Anthony Verrelli (Democratic). It lists 3 additional sponsors. Most recent recorded action (January 13, 2026): Withdrawn Because Approved P.L.2025, c.296.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Democratic 5

NameRolePartyChamberDistrict
Clinton CalabresePrimary sponsorDemocraticHouse36
Anthony VerrelliPrimary sponsorDemocraticHouse15
Kevin EganCo-sponsorDemocraticHouse17
Shama HaiderCo-sponsorDemocraticHouse37
Shanique SpeightCo-sponsorDemocraticHouse29

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Withdrawn Because Approved P.L.2025, c.296.
  2. Introduced, Referred to Assembly Health Committee

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source